Wellness During Tamoxifen Treatment: Integrative Oncology Approaches
References
Witt CM, Balneaves LG, Cardoso MJ, et al. A Comprehensive Definition for Integrative Oncology. J Natl Cancer Inst Monogr. 2017;2017(52):10.1093/jncimonographs/lgx012. doi:10.1093/jncimonographs/lgx012
2. Stagl JM, Lechner SC, Carver CS, et al. A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up. Breast Cancer Res Treat. 2015;154(2):319-328. doi:10.1007/s10549-015-3626-6
3. Kaplan M, Mahon SM, Lubejko BG, Ginex PK. Hot Flashes: Clinical Summary of the ONS Guidelines™ for Cancer Treatment-Related Hot Flashes in Women WithBreast Cancer and Men With Prostate Cancer. Clin J Oncol Nurs. 2020;24(4):430-433. doi:10.1188/20.CJON.430-433
4. Rada G, Capurro D, Pantoja T, et al. Non-hormonalinterventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev. 2010;(9):CD004923. Published 2010 Sep 8. doi:10.1002/14651858.CD004923.pub2
5. Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66(1):43-73. doi:10.3322/caac.21319
6. Carson JW, Carson KM, Porter LS, Keefe FJ, Seewaldt VL. Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial. Support Care Cancer. 2009;17(10):1301-1309. doi:10.1007/s00520-009-0587-5
7. Mann E, Smith MJ, Hellier J, et al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol. 2012;13(3):309-318. doi:10.1016/S1470-2045(11)70364-3
8. Greenlee H, DuPont-Reyes MJ, Balneaves LG, et al. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin. 2017;67(3):194-232. doi:10.3322/caac.21397
9. Chan YT, Wang N, Tam CW, et al. Systematic Review with Meta-Analysis: Effectiveness and Safety of Acupuncture as Adjuvant Therapy for Side Effects Management in Drug Therapy-Receiving Breast Cancer Patients. Evid Based Complement Alternat Med. 2021;2021:9949777. Published 2021 Oct 12. doi:10.1155/2021/9949777
10. Xue D, Sun H, Li PP. Long-term chinese herbs decoction administration for management of hot flashes associated with endocrine therapy in breast cancer patients. Chin J Cancer Res. 2011;23(1):74-78. doi:10.1007/s11670-011-0074-7
11. Hernández Muñoz G, Pluchino S. Cimicifuga racemosafor the treatment of hot flushes in women surviving breast cancer. Maturitas. 2003;44 Suppl 1:S59-S65. doi:10.1016/s0378-5122(02)00349-3
12. Wang C, Huang Q, Liang CL, et al. Effect of cimicifuga racemosa on menopausal syndrome caused by LHRH-a in breast cancer. J Ethnopharmacol. 2019;238:111840. doi:10.1016/j.jep.2019.111840
13. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol. 2001;19(10):2739-2745. doi:10.1200/JCO.2001.19.10.2739
14. Fritz H, Seely D, McGowan J, et al. Black cohosh and breast cancer: a systematic review. Integr Cancer Ther. 2014;13(1):12-29. doi:10.1177/1534735413477191
15. Furtado Macruz C, Lima SMRR. Effects of Cimicifuga racemosa (L.) Nutt on sexual function in women receiving tamoxifen for breast cancer. J Obstet Gynaecol. 2022;42(7):3236-3240. doi:10.1080/01443615.2022.2111517
16. Ee C, Kay S, Reynolds A, Lovato N, Lacey J, KoczwaraB. Lifestyle and integrative oncology interventions for cancer-related fatigue and sleep disturbances. Maturitas. 2024;187:108056. doi:10.1016/j.maturitas.2024.108056
17. Li Y, Gao L, Chao Y, et al. Various interventions for cancer-related fatigue in patients with breast cancer: a systematic review and network meta-analysis. Front Oncol. 2024;14:1341927. Published 2024 Feb 9. doi:10.3389/fonc.2024.1341927
18. Bower JE, Lacchetti C, Alici Y, et al. Management of Fatigue in Adult Survivors of Cancer: ASCO-Society for Integrative Oncology Guideline Update. J Clin Oncol. 2024;42(20):2456-2487. doi:10.1200/JCO.24.00541
19. Zhao H, Zhang Q, Zhao L, Huang X, Wang J, Kang X. Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial. Evid Based Complement Alternat Med. 2012;2012:809614. doi:10.1155/2012/809614
20. Seo K, Kim JH, Han D. Effects of Melatonin Supplementation on Sleep Quality in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Healthcare (Basel). 2023;11(5):675. Published 2023 Feb 24. doi:10.3390/healthcare11050675
21. Hansen MV, Andersen LT, Madsen MT, et al. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial. Breast Cancer Res Treat. 2014;145(3):683-695. doi:10.1007/s10549-014-2962-2
22. Lissoni P, Barni S, Meregalli S, et al. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer. 1995;71(4):854-856. doi:10.1038/bjc.1995.164
23. Innominato PF, Lim AS, Palesh O, et al. The effect of melatonin on sleep and quality of life in patients with advanced breast cancer. Support Care Cancer. 2016;24(3):1097-1105. doi:10.1007/s00520-015-2883-6
24. Zahrooni N, Hosseini SA, Ahmadzadeh A, Ahmadi Angali K, Assarehzadegan MA. The Effect of Coenzyme Q10 Supplementation on Vascular Endothelial Growth Factor and Serum Levels of Interleukin 6 and 8 in Women with Breast Cancer: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Ther Clin Risk Manag. 2019;15:1403-1410. Published 2019 Dec 4. doi:10.2147/TCRM.S234930
25. Yuvaraj S, Premkumar VG, Vijayasarathy K, GangadaranSG, Sachdanandam P. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin. Cancer Chemother Pharmacol. 2008;61(6):933-941. doi:10.1007/s00280-007-0547-z
26. Yuvaraj S, Premkumar VG, Shanthi P, Vijayasarathy K, Gangadaran SG, Sachdanandam P. Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles. Breast Cancer Res Treat. 2009;114(2):377-384. doi:10.1007/s10549-008-0012-7
27. Premkumar VG, Yuvaraj S, Shanthi P, Sachdanandam P. Co-enzyme Q10, riboflavin and niacin supplementation on alteration of DNA repair enzyme and DNA methylation in breast cancer patients undergoing tamoxifen therapy. Br J Nutr. 2008;100(6):1179-1182. doi:10.1017/S0007114508968276
28. Yuvaraj S, Premkumar VG, Vijayasarathy K, GangadaranSG, Sachdanandam P. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins. Clin Biochem. 2007;40(9-10):623-628. doi:10.1016/j.clinbiochem.2007.02.003
29. Hosseini SA, Zahrooni N, Ahmadzadeh A, AhmadiangaliK, Assarehzadegan MA. The Effect of CoQ10 Supplementation on Quality of Life in Women with Breast Cancer Undergoing Tamoxifen Therapy: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Psychol Res Behav Manag. 2020;13:151-159. Published 2020 Feb 20. doi:10.2147/PRBM.S241431
30. Muralikrishnan G, Amanullah S, Basha MI, Boopalan S, Vijayakumar S, Shakeel F. Effect of vitamin C on lipidperoxidation and antioxidant status in tamoxifen-treated breast cancer patients. Chemotherapy. 2010;56(4):298-302. doi:10.1159/000320030
31. Su YW, Huang WY, Lin SH, Yang PS. Effects of Reishimmune-S, a Fungal Immunomodulatory Peptide Supplement, on the Quality of Life and Circulating Natural Killer Cell Profiles of Patients With Early Breast Cancer Receiving Adjuvant Endocrine Therapy. Integr Cancer Ther. 2024;23:15347354241242120. doi:10.1177/15347354241242120
32. Nourozi B, Naghsh E, Esmaeilzadeh S, Mehrzad V, Darakhshandeh A, Moghaddas A. Omega-3 in the subjective betterment of mood and sleep disturbances induced by hormone therapy in women with breast cancer: a pilot, randomized, double-blinded, placebo-controlled clinical trial. Sleep Vigil. 2024;8:39–47. doi:10.1007/s41782-023-00249-0.
33. Cross T, George A, Attwood K, et al. Associations between Serum 25-Hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Patients with Breast Cancer: A Longitudinal Study. Cancer Epidemiol Biomarkers Prev. 2022;31(12):2126-2135. doi:10.1158/1055-9965.EPI-22-0343
34. Andersen MR, Sweet E, Hager S, Gaul M, Dowd F, Standish LJ. Effects of Vitamin D Use on Health-Related Quality of Life of Breast Cancer Patients in Early Survivorship. Integr Cancer Ther. 2019;18:1534735418822056. doi:10.1177/1534735418822056
35. Shapiro CL, Van Poznak C, Lacchetti C, et al. Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline. J Clin Oncol. 2019;37(31):2916-2946. doi:10.1200/JCO.19.01696
36. Spei ME, Samoli E, Bravi F, La Vecchia C, Bamia C, Benetou V. Physical activity in breast cancer survivors: A systematic review and meta-analysis on overall and breast cancer survival. Breast. 2019;44:144-152. doi:10.1016/j.breast.2019.02.001
37. Berrino F, Villarini A, Gargano G, et al. The Effect of Diet on Breast Cancer Recurrence: The DIANA-5 Randomized Trial. Clin Cancer Res. 2024;30(5):965-974. doi:10.1158/1078-0432.CCR-23-1615
38. Chi F, Wu R, Zeng YC, Xing R, Liu Y, Xu ZG. Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev. 2013;14(4):2407-2412. doi:10.7314/apjcp.2013.14.4.2407
39. Caan BJ, Natarajan L, Parker B, et al. Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev. 2011;20(5):854-858. doi:10.1158/1055-9965.EPI-10-1041
40. Zhang FF, Haslam DE, Terry MB, et al. Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry. Cancer. 2017;123(11):2070-2079. doi:10.1002/cncr.30615
41. Qiu S, Jiang C. Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis. Eur J Nutr. 2019;58(8):3079-3090. doi:10.1007/s00394-018-1853-4
42. Nechuta SJ, Caan BJ, Chen WY, et al. Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr. 2012;96(1):123-132. doi:10.3945/ajcn.112.035972
43. Yan Z, Zhang X, Li C, Jiao S, Dong W. Association between consumption of soy and risk of cardiovascular disease: A meta-analysis of observational studies. Eur J Prev Cardiol. 2017;24(7):735-747. doi:10.1177/2047487316686441
44. Flower G, Fritz H, Balneaves LG, et al. Flax and Breast Cancer: A Systematic Review. Integr Cancer Ther. 2014;13(3):181-192. doi:10.1177/1534735413502076
45. Yiannakopoulou EC. Interaction of green tea catechins with breast cancer endocrine treatment: a systematic review. Pharmacology. 2014;94(5-6):245-248. doi:10.1159/000369170
46. Gianfredi V, Nucci D, Abalsamo A, et al. Green Tea Consumption and Risk of Breast Cancer and Recurrence-A Systematic Review and Meta-Analysis of Observational Studies. Nutrients. 2018;10(12):1886. Published 2018 Dec 3. doi:10.3390/nu10121886
47. Harris HR, Orsini N, Wolk A. Vitamin C and survival among women with breast cancer: a meta-analysis. Eur J Cancer. 2014;50(7):1223-1231. doi:10.1016/j.ejca.2014.02.013
48. Kanellopoulou A, Riza E, Samoli E, Benetou V. Dietary Supplement Use after Cancer Diagnosis in Relation to Total Mortality, Cancer Mortality and Recurrence: A Systematic Review and Meta-Analysis. Nutr Cancer. 2021;73(1):16-30. doi:10.1080/01635581.2020.1734215
49. Thomson CA, Chow HHS, Wertheim BC, et al. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Res Treat. 2017;165(1):97-107. doi:10.1007/s10549-017-4292-7
50. Hussaarts KGAM, Hurkmans DP, Oomen-de Hoop E, et al. Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen. Cancers (Basel). 2019;11(3):403. Published 2019 Mar 22. doi:10.3390/cancers11030403
51. Meneses-Echávez JF, González-Jiménez E, Ramírez-Vélez R. Effects of supervised exercise on cancer-related fatigue in breast cancer survivors: a systematic review and meta-analysis. BMC Cancer. 2015;15:77. Published 2015 Feb 21. doi:10.1186/s12885-015-1069-4
Armenian SH. Anthracycline-Induced Cardiotoxicity in Young Cancer Patients: The Role of Carnitine. Ann Nutr Metab. 2016;68 Suppl 3:10-14. doi:10.1159/000448322
de Azambuja E. Cardiotoxicity in Oncology Practice. European Society for Medical Oncology. Published 2011. Accessed October 5, 2019. https://www.esmo.org/education/oncology-in-practice/cardiotoxicity
Stenger M. ASCO Clinical Practice Guideline on Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers. The ASCO Post. April 10, 2017. Accessed June 3, 2025. https://ascopost.com/issues/april-10-2017/asco-clinical-practice-guideline-on-prevention-and-monitoring-of-cardiac-dysfunction-in-survivors-of-adult-cancers/
Asnani A, Neilan T, Tripathy D, Scherrer-Crosbie, M. Clinical manifestations, monitoring, and diagnosis of anthracycline-induced cardiotoxicity. July 17, 2019. Viewed October 5, 2019.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Survivorship. Version 2.2025. ©2025. Accessed June 4, 2025. https://www.nccn.org
Friedman DL, Hudson MM, Landier W. Heart Health: Keeping Your Heart Healthy After Treatment for Childhood Cancer. Children’s Oncology Group. Version 4.0. http://survivorshipguidelines.org/pdf/healthlinks/English/heart_health_Eng.pdf. Published 2018. Accessed October 5, 2019.
Witt CM, Balneaves LG, Cardoso MJ, et al. A Comprehensive Definition for Integrative Oncology. J Natl Cancer Inst Monogr. 2017;2017(52):10.1093/jncimonographs/lgx012. doi:10.1093/jncimonographs/lgx012
Guasch-Ferré M, Salas-Salvadó J, Ros E, et al. The PREDIMED trial, Mediterranean diet and health outcomes: How strong is the evidence?. Nutr Metab Cardiovasc Dis. 2017;27(7):624-632. doi:10.1016/j.numecd.2017.05.004
Lichtenstein AH, Appel LJ, Vadiveloo M, et al. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2021;144(23):e472-e487. doi:10.1161/CIR.0000000000001031
Gardner CD, Vadiveloo MK, Petersen KS, et al. Popular Dietary Patterns: Alignment With American Heart Association 2021 Dietary Guidance: A Scientific Statement From the American Heart Association. Circulation. 2023;147(22):1715-1730. doi:10.1161/CIR.0000000000001146
Writing Committee Members, Virani SS, Newby LK, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines [published correction appears in J Am Coll Cardiol. 2023 Oct 31;82(18):1808. doi: 10.1016/j.jacc.2023.09.794.] [published correction appears in J Am Coll Cardiol. 2024 Apr 30;83(17):1716. doi: 10.1016/j.jacc.2024.03.399.]. J Am Coll Cardiol. 2023;82(9):833-955. doi:10.1016/j.jacc.2023.04.003
Rock CL, Thomson C, Gansler T, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin. 2020;70(4):245-271. doi:10.3322/caac.21591
Ubago-Guisado E, Rodríguez-Barranco M, Ching-López A, et al. Evidence Update on the Relationship between Diet and the Most Common Cancers from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: A Systematic Review. Nutrients. 2021;13(10):3582. Published 2021 Oct 13. doi:10.3390/nu13103582
Alizadehasl A, Malekzadeh Moghani M, Mirzaei H, et al. Cardioprotective Diet to Prevent Anthracycline-Induced Cardiotoxicity in Patients with Breast Cancer: A Randomized Open-Label Controlled Trial. J Integr Complement Med. 2024;30(10):995-1001. doi:10.1089/jicm.2023.0777
Barone Gibbs B, Hivert MF, Jerome GJ, et al. Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association. Hypertension. 2021;78(2):e26-e37. doi:10.1161/HYP.0000000000000196
Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;11(11):CD006145. Published 2012 Nov 14. doi:10.1002/14651858.CD006145.pub3
Dozic S, Howden EJ, Bell JR, Mellor KM, Delbridge LMD, Weeks KL. Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy. Cells. 2023;12(9):1312. Published 2023 May 4. doi:10.3390/cells12091312
Hornsby WE, Douglas PS, West MJ, et al. Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial. Acta Oncol. 2014;53(1):65-74. doi:10.3109/0284186X.2013.781673
Jones LW, Habel LA, Weltzien E, et al. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016;34(23):2743-2749. doi:10.1200/JCO.2015.65.6603
Segal R, Zwaal C, Green E, et al. Exercise for people with cancer: a clinical practice guideline. Curr Oncol. 2017;24(1):40-46. doi:10.3747/co.24.3376
Scott JM, Nilsen TS, Gupta D, Jones LW. Exercise Therapy and Cardiovascular Toxicity in Cancer. Circulation. 2018;137(11):1176-1191. doi:10.1161/CIRCULATIONAHA.117.024671
Levine GN, Cohen BE, Commodore-Mensah Y, et al. Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association. Circulation. 2021;143(10):e763-e783. doi:10.1161/CIR.0000000000000947
Twohig-Bennett C, Jones A. The health benefits of the great outdoors: A systematic review and meta-analysis of greenspace exposure and health outcomes. Environ Res. 2018;166:628-637. doi:10.1016/j.envres.2018.06.030
Rojas-Rueda D, Nieuwenhuijsen MJ, Gascon M, Perez-Leon D, Mudu P. Green spaces and mortality: a systematic review and meta-analysis of cohort studies [published correction appears in Lancet Planet Health. 2021 Aug;5(8):e504. doi: 10.1016/S2542-5196(21)00208-4.]. Lancet Planet Health. 2019;3(11):e469-e477. doi:10.1016/S2542-5196(19)30215-3
Pole L, Hepp N. Sourcing Quality Supplements at a Glance. CancerChoices. Updated June 4, 2023. Accessed June 3, 2025. https://cancerchoices.org/resources/reviews-of-complementary-therapies/sourcing-quality-herbs-supplements/
El Amrousy D, El-Afify D, Khedr R, Ibrahim AM. Omega 3 fatty acids can reduce early doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2022;69(7):e29496. doi:10.1002/pbc.29496
Hagag AA, El Shehaby WA, El-Abasy AI, Mabrouk MM. Protective Role of Silymarin in Early Doxorubicin-induced Cardiac Dysfunction in Children with Acute Lymphoblastic Leukemia. Infect Disord Drug Targets. 2019;19(2):133-140. doi:10.2174/1871526518666180803141827
Gurley BJ, Swain A, Hubbard MA, et al. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Mol Nutr Food Res. 2008;52(7):755-763. doi:10.1002/mnfr.200600300
Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto [published correction appears in Clin Pharmacol Ther. 2005 May;77(5):456]. Clin Pharmacol Ther. 2004;76(5):428-440. doi:10.1016/j.clpt.2004.07.007
Fuhr U, Beckmann-Knopp S, Jetter A, Lück H, Mengs U. The effect of silymarin on oral nifedipine pharmacokinetics. Planta Med. 2007;73(14):1429-1435. doi:10.1055/s-2007-990256
Goey AK, Mooiman KD, Beijnen JH, Schellens JH, Meijerman I. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients. Cancer Treat Rev. 2013;39(7):773-783. doi:10.1016/j.ctrv.2012.12.008
Moreno-Vega A, Vega-Riveroll L, Ayala T, et al. Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study. Nutrients. 2019;11(7):1623. Published 2019 Jul 17. doi:10.3390/nu11071623
Cao S, Xue J, Chen L, et al. Effects of the Chinese herbal medicine Hong Huang decoction, on myocardial injury in breast cancer patients who underwent anthracycline-based chemotherapy. Front Cardiovasc Med. 2022;9:921753. Published 2022 Jul 22. doi:10.3389/fcvm.2022.921753